CSL Behring Announces FDA Approval of Berinert, First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Links shared publicly online about this topic.
- 1,681total visits
CSL Behring Announces FDA Approval of Berinert, First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Berinert (C1 esterase inhibitor (human)) is used to treat hereditary angioedema. Includes Berinert side effects, interactions and indications.
View full resource at drugs.com
Tags: Angioedema, FDA, CSL
Most Recently Shared on October 12, 2009 at 11:38 pm By:
FDA Approves Berinert for Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema - http://bit.ly/lz9bc
Advertisement
